tiprankstipranks
Advertisement
Advertisement

HIMS Stock Latest News

FDA to ease restrictions on peptides, NY Times reports
The FlyFDA to ease restrictions on peptides, NY Times reports
23h ago
HIMS
Novo Nordisk launches multi-month subscription program for Wegovy
PremiumThe Fly
Novo Nordisk launches multi-month subscription program for Wegovy
1d ago
WW
NVO
Option traders moderately bearish in Hims and Hers Health with shares down 3.43%
PremiumThe Fly
Option traders moderately bearish in Hims and Hers Health with shares down 3.43%
2d ago
HIMS
Hims & Hers price target lowered to $23 from $25 at TD Cowen
PremiumThe Fly
Hims & Hers price target lowered to $23 from $25 at TD Cowen
5d ago
HIMS
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
PremiumRatings
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
5d ago
HIMS
HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
PremiumMarket NewsHIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
6d ago
BAC
NVO
Private Markets: OpenAI raises additional $10B funding
Premium
The Fly
Private Markets: OpenAI raises additional $10B funding
6d ago
DE
ZS
Hims & Hers GLP-1 subscription fee slightly higher than expected, says BofA
Premium
The Fly
Hims & Hers GLP-1 subscription fee slightly higher than expected, says BofA
6d ago
NVO
HIMS
Hims & Hers announces availability of Novo Nordisk’s GLP-1 medications
PremiumThe Fly
Hims & Hers announces availability of Novo Nordisk’s GLP-1 medications
6d ago
NVO
HIMS
Mixed options sentiment in Hims and Hers Health with shares up 3.87%
PremiumThe Fly
Mixed options sentiment in Hims and Hers Health with shares up 3.87%
13d ago
HIMS
Hims & Hers price target raised to $25 from $17.50 at Leerink
PremiumThe Fly
Hims & Hers price target raised to $25 from $17.50 at Leerink
16d ago
HIMS
Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts
PremiumWeekend Updates
Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts
18d ago
TU
NVO
Morning Movers: FireFly Aerospace skyrockets following Alpha Flight 7 launch
PremiumThe FlyMorning Movers: FireFly Aerospace skyrockets following Alpha Flight 7 launch
20d ago
DG
DKS
Hims & Hers (HIMS) Stock Rallies 58% in Five Days — Can the Momentum Last?
Premium
Market News
Hims & Hers (HIMS) Stock Rallies 58% in Five Days — Can the Momentum Last?
20d ago
NVO
HIMS
Hims & Hers revamps GLP-1 strategy with Novo Nordisk
Premium
Company Announcements
Hims & Hers revamps GLP-1 strategy with Novo Nordisk
21d ago
8K
HIMS
HIMS-Novo ‘Can’t Quit Each Other’ – Analysts Bullish on Wegovy Deal
PremiumMarket News
HIMS-Novo ‘Can’t Quit Each Other’ – Analysts Bullish on Wegovy Deal
21d ago
NVO
HIMS
Hims & Hers rises 14.5%
PremiumThe Fly
Hims & Hers rises 14.5%
21d ago
HIMS
Moderately bullish activity in Hims and Hers Health with shares up 11.29%
PremiumThe Fly
Moderately bullish activity in Hims and Hers Health with shares up 11.29%
21d ago
HIMS
Hims and Hers Health call volume above normal and directionally bullish
PremiumThe Fly
Hims and Hers Health call volume above normal and directionally bullish
21d ago
HIMS
Hims & Hers price target raised to $29 from $25 at Barclays
PremiumThe FlyHims & Hers price target raised to $29 from $25 at Barclays
21d ago
HIMS
Hims & Hers names Kathryn Beiser as Chief Communications Officer
Premium
The Fly
Hims & Hers names Kathryn Beiser as Chief Communications Officer
22d ago
HIMS
Hims & Hers rises 12.0%
Premium
The Fly
Hims & Hers rises 12.0%
22d ago
HIMS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >